Archives for October 2, 2005

← 2005

Angiotech and CombinatoRx in drug development deal

By  Wai Lang Chu

Angiotech has announced the formation of a drug discovery and development agreement with CombinatoRx that aims to focus on drug treatments for peripheral vascular, coronary, and orthopaedic disorders.

Integra launches automated petri dish filler

By  Wai Lang Chu

Integra Biosciences has launched its next generation system that enables automated filling of up to 540 Petri dishes at the push of a button. The technology utilises an agar-spread function that promises a 30 per cent saving on media use compared to...

Stem cells to have diagnostic tool application

By  Wai Lang Chu

Stem cells have the potential to become an effective diagnostic tool singling out those susceptible of atherosclerosis, say researchers. These cells could also help to predict regeneration of heart cells following a heart attack.

Scientists isolate new immune cell for drug target

By  Wai Lang Chu

US researchers have discovered a new immune cell that may play a key role in inflammatory and autoimmune diseases, which raises the prospect of finding ways to treat these disorders that include asthma, arthritis, and multiple sclerosis (MS).

Lacquer expands utility of Aclar films

By Phil Taylor

Hueck Folien has introduced a new heat sealing lacquer that should improve the barrier properties of blister packaging using Honeywell's Aclar fluoropolymer films.

CEM sets up manufacturing-scale microwave division

By Phil Taylor

CEM Corp has announced the formation of a division within the company that will be focused on developing systems for scaling up reactions performed using microwave synthesis.

BASF completes orgamol acquisition

German chemical company BASF has completed its acquisition of Orgamol, a transaction designed to boost its service offering to the pharmaceutical sector.

Drug developers encouraged by 'cure all' drug

By  Wai Lang Chu

European researchers have come up with a basis for a drug that can treat diabetes, cancer and prevent vessel occlusion. The researchers believe that new compounds could be developed in the future which are more selective, more effective and have less...